Avsar.

Healthcare · Pharmaceuticals

Innova Captab Ltd (INNOVACAP)

₹1,172.60

Mkt cap
₹6,726 Cr
P/E ratio
43.70
P/B
6.14
Div yield
0.17%
ROE
13.70%
ROCE
15.00%
EPS (TTM)
₹26.83
Book value
₹191
52W range
645–1,179
Sector
Healthcare

Price history

Previous close

Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain. [1]

NSE INNOVACAPBSE 544067
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthHigh
TechnicalsBullish
52-week range
−0.53% from high
₹1,173
₹645+81.87% from low₹1,179
Current
₹1,172.60
Prev close
₹1,178.90
Day
−0.53%
Price performance
1D
−0.53%
1W
+8.77%
1M
+24.15%
3M
+28.20%
6M
+81.21%
1Y
+25.89%
YTD
+61.70%

Financials

Revenue, profit & margin
P/E ratio
43.7×
INNOVACAP is 29% above the sector median of 34.0×
INNOVACAP43.7×
Sector median34.0×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales233283302263294318316315352380450448471
Expenses202242258225252268270267299329381383398
Operating Profit31404538425047485252696573
OPM %13%14%15%14%14%16%15%15%15%14%15%15%16%
Other Income1326224344222
Interest5971000236454
Depreciation3553555101111111112
Profit before tax25303540394746394339565159
Tax %28%24%29%27%25%25%25%25%27%24%24%25%25%
Net Profit18232529293534303130423844
EPS in Rs3.664.774.395.025.156.125.985.175.425.187.376.657.71
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −1.50% · closed higher next day 1 of last 2
 Q4FY26†Q1FY27
Broadcast22 Aug '26◦11 Aug '26◦
Earnings day−2.34%−0.66%
+1 day−4.42%+2.81%
+5 days−0.96%+2.05%
+15 days—+8.80%
+30 days——
FilingXBRLPDF

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Results analysis

Shareholding

as of Jun 2026
50.90%Promoter
Promoters50.90%
FIIs0.34%0.11
DIIs19.92%0.22
Public28.84%0.10
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
SUNPHARMA₹1,899.0036.074,55,6340.84%2,901+5.95%15,300+10.46%20.53%
DIVISLAB₹9,100.0081.092,41,5760.33%902+65.50%3,080+27.80%21.97%
TORNTPHARM₹4,857.0082.801,84,7450.78%566+5.79%4,921+54.85%15.19%
CIPLA₹1,385.0031.261,11,8880.94%786−39.19%7,119+2.33%15.49%
ZYDUSLIFE₹1,120.0022.951,11,7200.09%990−35.09%8,017+21.96%21.14%
LAURUSLABS₹1,840.0090.9399,4170.11%362+125.49%2,026+29.10%17.76%
LUPIN₹2,110.0016.2096,4830.85%1,417+16.08%8,277+32.04%29.93%
INNOVACAP₹1,175.4043.676,7260.17%44+42.26%471+33.94%14.96%
Median: 158 Co.₹421.5033.962,2770.08%13+30.25%164+18.67%14.96%

Filings

Annual reports3
Annual Report 2026bseAnnual Report 2025bseAnnual Report 2024bse
Concall transcripts32
PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptFeb 2025PPTFeb 2025RECFeb 2025TranscriptNov 2024PPTNov 2024RECNov 2024
Credit ratings6
Rating update 17 AprcareRating update 19 Sep 2025careRating update 4 Sep 2024careRating update 27 Sep 2023careRating update 30 May 2023careRating update 7 Feb 2023care
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 5 Sep - Pursuant to the regulation 30 read with schedule III, Part A, Para A and regulation 47 of SEBI (LODR) Regulations, 2015 ("Listing regulations") ....Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 5 Sep - Innova Captab schedules 22nd AGM on 30 September 2026; annual report 2025-26 and e-voting dates shared.Business Responsibility and Sustainability Reporting (BRSR) 4 Sep - Innova Captab submitted its BRSR for FY 2025-26, forming part of the Integrated Annual Report.Reg. 34 (1) Annual Report. 4 SepNotice Convening The 22Nd Annual General Meeting ('AGM') And Submission Of Integrated Annual Report Of The Company For The Financial Year 2025-2026. 4 Sep